Pro Medicus: Expensive for a reason

By Iain Wilkie

18 August 2022, 4:00 PM

Pro Medicus (ASX:PME) recorded another year of strong growth across all metrics with the key highlight being further EBIT margin expansion to 67% well above expectations, highlighting the operating leverage of the business.

Results 1-10 of 500
  • Print this page
  • Copy Link